Playback speed
10 seconds
Preliminary Results of Phase II Trial of Brentuximab Vedotin and Lenalidomide in Relapsed / Refractory Cutaneous / Peripheral T-Cell Lymphomas
17 views
October 18, 2019
Login to view comments.
Click here to Login